Current Protein Identity:P23819 New Search
Main Difference Dimensions in This Set
Different construct Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
8I0B The crystal structure of human glutamate receptor 2 in complex with LT-102 Deposited 2023-01-10 Assembly 1 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 413–527(115 aa)
Chain B 413–527(115 aa)
Not recorded SO4 SULFATE ION × 4 NXO 8-[4-(2-fluorophenyl)phenyl]-3,4-dihydro-1,2$l^{6},3-benzoxathiazine 2,2-dioxide × 1 NA SODIUM ION × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;22% PEG 8000, 0.1M NaAC pH 5.0, 0.2M (NH4)2SO4
Resolution 1.73 Å R-free 0.278
9Z6U The structure of TMD with 2 TARPs and 2 CNIHs from all native AMPA receptor subtypes Deposited 2025-11-14 Assembly 1 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain B 532–568(37 aa)
Chain B 590–651(62 aa)
Chain B 805–841(37 aa)
Chain D 532–568(37 aa)
Chain D 590–651(62 aa)
Chain D 805–841(37 aa)
Not recorded POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 20 C14 TETRADECANE × 18 XVD 6-[2-chloro-6-(trifluoromethoxy)phenyl]-1H-benzimidazol-2-ol × 2 D12 DODECANE × 6 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.87 Å
9Z6V The structure of TMD with 3 TARPs and 1 CNIH from all native AMPA receptor subtypes Deposited 2025-11-14 Assembly 1 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain B 532–568(37 aa)
Chain B 590–651(62 aa)
Chain B 805–841(37 aa)
Chain D 532–568(37 aa)
Chain D 590–651(62 aa)
Chain D 805–841(37 aa)
Not recorded POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 23 C14 TETRADECANE × 3 XVD 6-[2-chloro-6-(trifluoromethoxy)phenyl]-1H-benzimidazol-2-ol × 2 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.00 Å
9Z6W The structure of TMD with 4 TARPs from all native AMPA receptor subtypes Deposited 2025-11-14 Assembly 1 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain B 532–568(37 aa)
Chain B 590–651(62 aa)
Chain B 805–841(37 aa)
Chain D 532–568(37 aa)
Chain D 590–651(62 aa)
Chain D 805–841(37 aa)
Not recorded POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 8 C14 TETRADECANE × 18 OCT N-OCTANE × 2 XVD 6-[2-chloro-6-(trifluoromethoxy)phenyl]-1H-benzimidazol-2-ol × 2 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.99 Å